Stroke is the second leading cause of death globally and accounts for an estimated 5.5 million deaths each year worldwide.[1]Revascularization of the carotid artery is one of the key procedures to reduce the incidence...Stroke is the second leading cause of death globally and accounts for an estimated 5.5 million deaths each year worldwide.[1]Revascularization of the carotid artery is one of the key procedures to reduce the incidence of stroke.Chronic total occlusion(TO)and near-total occlusion(NO)of the carotid artery are rare.Treatment for TO and NO is controversial with potential complications,including periprocedural stroke,intracranial hemorrhage,and carotid-cavernous fistula(CCF).[2]There have been attempts to implement carotid artery endarterectomy(CEA)and endovascular treatment,but the success rates were far from satisfactory.For patients with TO,the success rate of revascularization is around 40%and 60%,respectively,for CEA and endovascular technique.[3]For patients with NO,the morbidity and mortality rates are 3%and 9%,respectively.展开更多
文摘Stroke is the second leading cause of death globally and accounts for an estimated 5.5 million deaths each year worldwide.[1]Revascularization of the carotid artery is one of the key procedures to reduce the incidence of stroke.Chronic total occlusion(TO)and near-total occlusion(NO)of the carotid artery are rare.Treatment for TO and NO is controversial with potential complications,including periprocedural stroke,intracranial hemorrhage,and carotid-cavernous fistula(CCF).[2]There have been attempts to implement carotid artery endarterectomy(CEA)and endovascular treatment,but the success rates were far from satisfactory.For patients with TO,the success rate of revascularization is around 40%and 60%,respectively,for CEA and endovascular technique.[3]For patients with NO,the morbidity and mortality rates are 3%and 9%,respectively.
